News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,942 Results
Type
Article (34689)
Company Profile (162)
Press Release (523086)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (155383)
Career Advice (808)
Deals (25335)
Drug Delivery (83)
Drug Development (59939)
Employer Resources (81)
FDA (14389)
Job Trends (11971)
News (260549)
Policy (24310)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2322)
Accelerated approval (19)
Adcomms (11)
Allergies (128)
Alliances (43675)
ALS (114)
Alzheimer's disease (1268)
Antibody-drug conjugate (ADC) (246)
Approvals (14735)
Artificial intelligence (492)
Autoimmune disease (118)
Automation (33)
Bankruptcy (211)
Best Places to Work (9757)
BIOSECURE Act (10)
Biosimilars (92)
Biotechnology (118)
Bladder cancer (132)
Brain cancer (48)
Breast cancer (495)
Cancer (3841)
Cardiovascular disease (305)
Career advice (728)
Career pathing (20)
CAR-T (244)
CDC (29)
Celiac Disease (2)
Cell therapy (628)
Cervical cancer (35)
Clinical research (52021)
Collaboration (1506)
Compensation (434)
Complete response letters (24)
COVID-19 (2107)
CRISPR (89)
C-suite (696)
Cystic fibrosis (99)
Data (5096)
Decentralized trials (2)
Denatured (37)
Depression (103)
Diabetes (390)
Diagnostics (6116)
Digital health (41)
Diversity (11)
Diversity, equity & inclusion (18)
Drug discovery (205)
Drug pricing (104)
Drug shortages (24)
Duchenne muscular dystrophy (171)
Earnings (57570)
Editorial (36)
Employer branding (12)
Employer resources (74)
Events (80530)
Executive appointments (806)
FDA (17103)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (1168)
Gene editing (184)
Generative AI (43)
Gene therapy (466)
GLP-1 (703)
Government (3599)
Grass and pollen (6)
Guidances (322)
Healthcare (15632)
HIV (49)
Huntington's disease (25)
IgA nephropathy (60)
Immunology and inflammation (120)
Immuno-oncology (33)
Indications (83)
Infectious disease (2315)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (97)
Intellectual property (192)
Interviews (102)
IPO (11007)
IRA (29)
Job creations (2575)
Job search strategy (624)
JPM (32)
Kidney cancer (12)
Labor market (49)
Layoffs (284)
Leadership (13)
Legal (4983)
Liver cancer (77)
Longevity (11)
Lung cancer (548)
Lymphoma (302)
Machine learning (38)
Management (30)
Manufacturing (612)
MASH (121)
Medical device (14460)
Medtech (14512)
Mergers & acquisitions (15114)
Metabolic disorders (914)
Multiple sclerosis (120)
NASH (12)
Neurodegenerative disease (227)
Neuropsychiatric disorders (53)
Neuroscience (2168)
NextGen: Class of 2026 (5423)
Non-profit (3454)
Now hiring (39)
Obesity (375)
Opinion (169)
Ovarian cancer (145)
Pain (173)
Pancreatic cancer (171)
Parkinson's disease (208)
Partnered (25)
Patents (393)
Patient recruitment (410)
Peanut (53)
People (48906)
Pharmaceutical (29)
Pharmacy benefit managers (18)
Phase 1 (16110)
Phase 2 (22722)
Phase 3 (17525)
Pipeline (4074)
Policy (161)
Postmarket research (1812)
Preclinical (6230)
Press Release (67)
Prostate cancer (199)
Psychedelics (27)
Radiopharmaceuticals (240)
Rare diseases (570)
Real estate (4672)
Recruiting (33)
Regulatory (19228)
Reports (22)
Research institute (2141)
Resumes & cover letters (116)
Rett syndrome (26)
RNA editing (11)
RSV (58)
Schizophrenia (123)
Series A (194)
Series B (143)
Service/supplier (7)
Sickle cell disease (61)
Special edition (9)
Spinal muscular atrophy (124)
Sponsored (30)
Startups (3237)
State (2)
Stomach cancer (12)
Supply chain (78)
Tariffs (31)
The Weekly (37)
Vaccines (772)
Venture capital (54)
Weight loss (240)
Women's health (70)
Worklife (6)
Date
Today (10)
Last 7 days (417)
Last 30 days (1663)
Last 365 days (22722)
2026 (2085)
2025 (23147)
2024 (27770)
2023 (31934)
2022 (42322)
2021 (45784)
2020 (44600)
2019 (39176)
2018 (29799)
2017 (26822)
2016 (25763)
2015 (30045)
2014 (22832)
2013 (19214)
2012 (20808)
2011 (21296)
2010 (19659)
Location
Africa (541)
Alabama (76)
Alaska (7)
Arizona (241)
Arkansas (13)
Asia (35131)
Australia (5919)
California (8098)
Canada (2635)
China (980)
Colorado (376)
Connecticut (399)
Delaware (287)
Europe (74363)
Florida (1338)
Georgia (301)
Hawaii (3)
Idaho (50)
Illinois (715)
India (45)
Indiana (438)
Iowa (17)
Japan (404)
Kansas (121)
Kentucky (28)
Louisiana (22)
Maine (36)
Maryland (1137)
Massachusetts (5549)
Michigan (321)
Minnesota (518)
Mississippi (5)
Missouri (119)
Montana (30)
Nebraska (26)
Nevada (84)
New Hampshire (83)
New Jersey (2433)
New Mexico (22)
New York (2214)
North Carolina (1125)
North Dakota (10)
Northern California (3771)
Ohio (286)
Oklahoma (18)
Oregon (37)
Pennsylvania (1689)
Puerto Rico (22)
Rhode Island (43)
South America (785)
South Carolina (66)
South Dakota (1)
Southern California (3245)
Tennessee (144)
Texas (1338)
United States (30143)
Utah (288)
Vermont (1)
Virginia (179)
Washington D.C. (58)
Washington State (712)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
557,942 Results for "shine medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO
January 5, 2026
·
4 min read
Press Releases
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
January 6, 2026
·
2 min read
Business
SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility
SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative radiopharmaceuticals.
June 6, 2024
·
3 min read
Press Releases
Biolinq Shine™ Granted De Novo Classification by U.S. FDA for the First Fully Autonomous, Needle-Free Glucose Sensor
September 26, 2025
·
3 min read
C-suite
Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline this past month.
BioSpace
caught up with Arrowhead’s Chris Anzalone to talk about the biotech’s role as an RNAi pipeline savior.
August 12, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations
January 30, 2025
·
4 min read
Press Releases
Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology Following SHINE Prediabetes Study Success
March 10, 2025
·
2 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
·
3 min read
BioMidwest
SHINE Technologies to Exhibit at 7th Annual Theranostics World Congress
SHINE Technologies will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile.
March 18, 2024
·
2 min read
Policy
SHINE Technologies, LLC Announces Submission of FDA Drug Master File for Non-Carrier-Added Lutetium-177
SHINE Technologies, LLC, a pioneer in next-generation fusion-based technology, becomes North America’s largest producer of non-carrier added lutetium-177 chloride, a cutting-edge radiopharmaceutical used in precision cancer treatment, with a Drug Master File to the U.S. Food and Drug Administration.
April 8, 2024
·
3 min read
1 of 55,795
Next
